Moderna CMO: Israel among countries first in line for vaccine

Tal Zaks / Photo: Moderna YouTube page
Tal Zaks / Photo: Moderna YouTube page

Dr. Tal Zaks told "Globes" that "Israel was one of the first countries that believed in us."

Dr. Tal Zaks, chief medical officer at Moderna Therapeutics, who was educated at Ben Gurion University of the Negev, told "Globes" today that, thanks to the agreement signed with Moderna in advance, Israel will be among the first countries to receive doses of the company's vaccine against Covid-19, production of which has already started. "Israel was one of the first countries that believed in us. The advance that Israel paid helped to build the company's production lines. Together with other countries that reserved doses in advance, it will receive doses that have already started being produced in Switzerland by our partner Lonza." Moderna also has its own plant in the US, and it too has started to produce doses of the vaccine, but these are reserved for the US market.

Zaks said that Israel had reserved "no small quantity" of vaccinations. The company is due to meet the US Food and Drug Administration (FDA) within the next few weeks. It will present to the FDA the safety data gathered over two months from all the volunteers in its clinical trial of the vaccine, and it can already present effectiveness data for 151 patients. If all goes according to plan, sales of the vaccine will be able to start in December.

"The results are very exciting, and match the optimism we had thanks to the good results in the Phase I trial in which we demonstrated that we succeed in producing a large number of neutralizing antibodies. After we saw Pfizer's results, we were altogether optimistic. I think that these results strengthen the optimism not just about RNA immunizations, but in general the correlation between neutralizing antibodies and a genuine good result in humans, that is to say, they strengthen the chances that the other vaccines that have successfully passed Phase I trials will succeed, and I wish all of them success."

Zaks added that in addition to the fact that only five patients who fell ill with Covid-19 in Moderna's trial were in the trial group, versus 90 patients in the control group, all the patients who were severely ill with the disease were in the control group. It is therefore possible that, in addition to preventing the disease, the vaccine also protects against severe illness for those who nevertheless contract it, despite being immunized. This, however, is still only a hypothesis on the basis of a small amount of data, and it will have to be examined again on the full sample.

Is it already possible to now for how long the vaccine will be effective?

""We think, in the light of the good level of effectiveness and the high levels of neutralizing antibodies in the blood, that the vaccine will be effective for at least a good few months. In pandemic conditions, that confirms the expectation that we will be able to eradicate the contagion. Will we need to receive a boost after a year or every few years? That is harder to know."

Moderna's vaccine can be transported at minus 20 degrees Celsius, but even outside of a freezer at this temperature it can last another 30 days in an ordinary refrigerator, so that it can fairly easily be transported over long distances.

"But we still need to be a little patient," Zaks concludes. "Just a for a little more time to protect ourselves with the existing methods."

Published by Globes, Israel business news - en.globes.co.il - on November 16, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Tal Zaks / Photo: Moderna YouTube page
Tal Zaks / Photo: Moderna YouTube page
DeepSeek credit: Reuters/VCG Wiz finds serious information leak at DeepSeek

The Chinese AI application that has taken the world by storm had a sensitive database exposed to anyone on the Internet.

US spec Mazda 3  credit: PR Tough EU regulations removing popular cars from Israel

New safety standards and average emission rules are making manufacturers drop models, or switch to US and Canadian standards for the Israeli market.

Amnon Shashua  credit: Yonatan Hefner Mobileye falls on disappointing 2025 guidance

The Israeli advanced driving assistance systems company predicts revenue of $1.69-1.81 billion in 2025, below the analysts' forecast of $1.96 billion.

Trophy protection system installed on Israeli tank credit: Rafael spokesperson Rafael adapts Trophy tank protection system for aerial threats

Trophy can now not only thwart anti-tank missiles but also low-flying aerial threats including helicopters and drones, the "Bulgarian Military" website reports.

Gasoline prices credit: Tali Bogdanovsky Gasoline prices in Israel to rise Saturday night

The maximum price of government price controlled 95 octane gasoline at self-service pumps in Israel will rise on Saturday at midnight February 2, 2025, by NIS 0.11 per liter to NIS 7.31 per liter, the Ministry of Energy and Infrastructure has announced.

Gil Shwed and Nadav Zafrir credit: Menash Cohen Check Point beats analysts in Q4 with strong growth

New CEO Nadav Zafrir: Check Point’s future is bright, and we are focused on driving market share expansion and taking growth to the next levels.

Air India credit: Shutterstock Air India to inaugurate Tel Aviv-Mumbai route

The announcement comes a week after Air India said it would resume Tel Aviv-Delhi flights in March.

Guardknox founders Photo: Tom Bergman Car cybersecurity co GuardKnox seeks court protection

The Israeli startup, which has raised $60 million, has ongoing liabilities of NIS 11 million that it will struggle to repay without legal arrangements.

Paragon founders credit: PR Paragon sale completed before Defense Ministry approval

US private equity firm AE Industrial Partners has already paid $900 million for Israeli cyberattack company Paragon, even though the Defense Ministry is still examining the deal.

Iron Beam credit: Ministry of Defense spokesperson Israel's Iron Beam set for deployment this year

Rafael chairman Yuval Steinitz told US website "National Defense" that the laser air defense system is continuing to improve its range.

Israel Bar Association chairperson Adv. Amit Becher credit: Noam Moskowitz, Knesset Spokesperson's Office Israel Bar Association under siege

The lawyers' association sees legislation to weaken it, and ultimately abolish it, as revenge for its stance against the government's judicial overhaul program.

Cybersecurity credit: Shutterstock Tenable acquires Israeli co Vulcan Cyber

This is the US data security company's third acquisition in Israel over the past five years.

Teva CEO Richard Francis credit: Elad Malka Teva falls sharply on disappointing 2025 guidance

The Israeli pharmaceuticals company reported strong fourth quarter results but its 2025 outlook did not meet expectations.

UVeye founders Ohad and Amir Hever credit: Yuval Chen Israeli AI vehicle inspection co UVeye raises $191m

UVeye’s systems, which are an “MRI for vehicles,” deliver precise, data-driven insights by scanning all visible vehicle components in a matter of seconds.

Beny Steinmetz credit: Reuters Denis Balibouse Greek court orders extradition of Beny Steinmetz to Romania

Steinmetz's lawyer Stavros Togias insists that the Athens court's decision contradicts a previous decision made by the court in 2022.

Shekel credit: Shutterstock Vladirina 32 Analysts see pay rises pushing inflation higher

A very tight labor market is creating upward pressure on wages that could upset the Bank of Israel's inflation projections.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018